CHNC — Cannabis Bioscience International Holdings Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $5.00m
- $14.14m
- $83.46m
Annual income statement for Cannabis Bioscience International Holdings, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2007 December 31st | 2008 May 31st | C2009 May 31st | C2010 May 31st | 2011 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 39.3 | 66.8 | 74 | 83.5 |
Cost of Revenue | |||||
Gross Profit | 0 | 6.25 | 13 | 18 | 27.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 0.056 | 34 | 55.7 | 87.3 | 69.2 |
Operating Profit | -0.056 | 5.26 | 11.1 | -13.3 | 14.3 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.056 | 5.08 | 11.1 | -12.6 | 14.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.056 | 5.08 | 11.1 | -12.6 | 11.2 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -0.056 | 4.8 | 10.5 | -13.4 | 10.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.056 | 4.8 | 10.5 | -13.4 | 10.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.18 | 4 | 7.4 | -1.72 | 0.836 |
Dividends per Share |